LARP1 isoform expression in human cancer cell lines.


Journal

RNA biology
ISSN: 1555-8584
Titre abrégé: RNA Biol
Pays: United States
ID NLM: 101235328

Informations de publication

Date de publication:
02 2021
Historique:
pubmed: 15 4 2020
medline: 1 12 2021
entrez: 15 4 2020
Statut: ppublish

Résumé

LARP1 is an oncogenic RNA-binding protein required for ribosome biogenesis and cancer cell survival. From published

Identifiants

pubmed: 32286153
doi: 10.1080/15476286.2020.1744320
pmc: PMC7928056
doi:

Substances chimiques

Autoantigens 0
Protein Isoforms 0
RNA-Binding Proteins 0
Ribonucleoproteins 0
RNA 63231-63-0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

237-247

Subventions

Organisme : Medical Research Council
ID : MR/M009157/1
Pays : United Kingdom
Organisme : Cancer Research UK
ID : 22598
Pays : United Kingdom

Références

Curr Opin Struct Biol. 2013 Jun;23(3):443-50
pubmed: 23706950
Proc Natl Acad Sci U S A. 2010 Dec 14;107(50):21931-6
pubmed: 21106759
Nat Genet. 2002 Jan;30(1):13-9
pubmed: 11753382
Genome Res. 2002 Jun;12(6):996-1006
pubmed: 12045153
J Biol Chem. 2015 Jun 26;290(26):15996-6020
pubmed: 25940091
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Trends Biochem Sci. 2017 Feb;42(2):98-110
pubmed: 27712956
Cell. 2019 Sep 5;178(6):1465-1477.e17
pubmed: 31491388
Gene. 2013 Feb 1;514(1):1-30
pubmed: 22909801
Mol Cell. 2019 Oct 17;76(2):329-345
pubmed: 31626751
Annu Rev Pharmacol Toxicol. 2005;45:629-56
pubmed: 15822191
Anal Biochem. 1984 Apr;138(1):141-3
pubmed: 6731838
RNA. 2009 May;15(5):750-64
pubmed: 19299548
Nucleic Acids Res. 2010 Sep;38(16):5542-53
pubmed: 20430826
Nature. 1986 May 15-21;321(6067):209-13
pubmed: 2423876
Mol Cell. 2012 Jun 29;46(6):884-92
pubmed: 22749401
Mol Cell. 2012 Jun 29;46(6):871-83
pubmed: 22749400
Genes Dev. 1997 Nov 1;11(21):2755-66
pubmed: 9353246
Biomolecules. 2015 Oct 16;5(4):2701-22
pubmed: 26501340
Trends Genet. 2004 Feb;20(2):68-71
pubmed: 14746986
Nucleic Acids Res. 2016 Feb 18;44(3):1227-46
pubmed: 26717985
Nucleic Acids Res. 2018 Jan 4;46(D1):D794-D801
pubmed: 29126249
Tumour Biol. 2016 Nov;37(11):14585-14594
pubmed: 27614686
Nat Rev Genet. 2010 May;11(5):345-55
pubmed: 20376054
Oncogene. 2015 Sep 24;34(39):5025-36
pubmed: 25531318
Nucleic Acids Res. 2019 Jan 8;47(D1):D506-D515
pubmed: 30395287
Dev Biol. 2009 Oct 1;334(1):186-97
pubmed: 19631203
Recent Results Cancer Res. 1983;84:202-11
pubmed: 6189159
Nat Biotechnol. 2010 Aug;28(8):817-25
pubmed: 20657582
Bioessays. 2003 Nov;25(11):1031-4
pubmed: 14579243
Nat Rev Genet. 2012 Mar 13;13(4):227-32
pubmed: 22411467
Cold Spring Harb Protoc. 2010 Jun;2010(6):pdb.prot5439
pubmed: 20516177
Nature. 2010 Jan 28;463(7280):457-63
pubmed: 20110989
Nat Rev Cancer. 2006 Oct;6(10):813-23
pubmed: 16990858
Biochem Soc Trans. 2016 Oct 15;44(5):1185-1200
pubmed: 27911701
Genes Dev. 2014 Feb 15;28(4):357-71
pubmed: 24532714
Nat Commun. 2017 Jul 19;8:16027
pubmed: 28722025
Nat Rev Mol Cell Biol. 2018 May;19(5):327-341
pubmed: 29339797
Nat Rev Mol Cell Biol. 2014 Nov;15(11):703-8
pubmed: 25315270
Biochimie. 2014 May;100:18-26
pubmed: 24120687
Elife. 2017 Apr 07;6:
pubmed: 28379136
Nucleic Acids Res. 2016 Jan 4;44(D1):D726-32
pubmed: 26527727
Elife. 2017 Jun 26;6:
pubmed: 28650797

Auteurs

Hagen Schwenzer (H)

Department of Oncology, University of Oxford, Oxford, UK.

Mai Abdel Mouti (M)

Department of Oncology, University of Oxford, Oxford, UK.

Pia Neubert (P)

Department of Oncology, University of Oxford, Oxford, UK.

Josephine Morris (J)

Department of Oncology, University of Oxford, Oxford, UK.

Joanne Stockton (J)

Institute of Cancer & Genomic Sciences, University of Birmingham, Birmingham, UK.

Sarah Bonham (S)

Target Discovery Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.

Martin Fellermeyer (M)

Department of Oncology, University of Oxford, Oxford, UK.

James Chettle (J)

Department of Oncology, University of Oxford, Oxford, UK.

Roman Fischer (R)

Target Discovery Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.

Andrew D Beggs (AD)

Institute of Cancer & Genomic Sciences, University of Birmingham, Birmingham, UK.

Sarah P Blagden (SP)

Department of Oncology, University of Oxford, Oxford, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH